Anna Tsimelzon

7.8k citations

62 papers · 5.1k indexed · 2 hit papers · h-index 33

Molecular Biology top 2%
Oncology top 1%
Cancer Research top 0.5%
Genetics top 2%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Susan G. Hilsenbeck Jenny C. Chang C. Kent Osborne Powel H. Brown Suzanne A.W. Fuqua Gordon B. Mills Syed K. Mohsin D. Craig Allred
Topics: Breast Cancer Treatment Studies (16 papers)Estrogen and related hormone effects (14 papers)Cancer Cells and Metastasis (12 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: The Lancet Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States Italy Switzerland

In The Last Decade

Anna Tsimelzon

61 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

2014 936 citations Matthew D. Burstein, Anna Tsimelzon et al. Clinical Cancer Research profile →
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

2003 668 citations Jenny C. Chang, Eric C. Wooten et al. The Lancet profile →

Peers

Countries citing papers authored by Anna Tsimelzon

Since Specialization

Citations

This map shows the geographic impact of Anna Tsimelzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tsimelzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tsimelzon more than expected).

Fields of papers citing papers by Anna Tsimelzon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tsimelzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tsimelzon. The network helps show where Anna Tsimelzon may publish in the future.

Co-authorship network of co-authors of Anna Tsimelzon

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tsimelzon. A scholar is included among the top collaborators of Anna Tsimelzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tsimelzon. Anna Tsimelzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival 2016 ·Cancer Research ·Petra den Hollander,(unknown),Anna Tsimelzon,Jonathan H. Shepherd,Abhijit Mazumdar,Jamal Hill,Suzanne A.W. Fuqua,Jenny C. Chang,C. Kent Osborne,Susan G. Hilsenbeck,Gordon B. Mills,Powel H. Brown	70
2	Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion 2016 ·Breast Cancer Research and Treatment ·Abhijit Mazumdar,Graham M. Poage,Jonathan H. Shepherd,Anna Tsimelzon,Zachary C. Hartman,Petra den Hollander,Jamal Hill,Yun Zhang,Jenny C. Chang,Susan G. Hilsenbeck,Suzanne A.W. Fuqua,C. Kent Osborne,Gordon B. Mills,Powel H. Brown	22
3	Intratumoral Heterogeneity in a Trp53 -Null Mouse Model of Human Breast Cancer 2015 ·Cancer Discovery ·Mei Zhang,Anna Tsimelzon,(unknown),Cheng Fan,Andrew A. Wolff,Charles M. Perou,Susan G. Hilsenbeck,Jeffrey M. Rosen	54
4	Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer 2015 ·Breast Cancer Research and Treatment ·(unknown),Yassine Rechoum,Guowei Gu,Luca Gelsomino,Amanda Beyer,Lauren Brusco,Kyle R. Covington,Anna Tsimelzon,Suzanne A.W. Fuqua	44
5	Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancerbreakdown → 2014 ·Clinical Cancer Research ·Matthew D. Burstein,Anna Tsimelzon,Graham M. Poage,Kyle R. Covington,Alejandro Contreras,Suzanne A.W. Fuqua,Michelle I. Savage,C. Kent Osborne,Susan G. Hilsenbeck,Jenny C. Chang,Gordon B. Mills,Ching C. Lau,Powel H. Brown	936
6	Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8 2013 ·Cancer Research ·Zachary C. Hartman,Graham M. Poage,Petra den Hollander,Anna Tsimelzon,Jamal Hill,Nattapon Panupinthu,Yun Zhang,Abhijit Mazumdar,Susan G. Hilsenbeck,Gordon B. Mills,Powel H. Brown	341
7	SRC-2 Coactivator Deficiency Decreases Functional Reserve in Response to Pressure Overload of Mouse Heart 2012 ·PLoS ONE ·Erin L. Reineke,Brian York,Erin Stashi,Xian Chen,Anna Tsimelzon,Jianming Xu,Christopher B. Newgard,George E. Taffet,Heinrich Taegtmeyer,Mark L. Entman,Bert W. O’Malley	23
8	Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells 2011 ·Clinical Cancer Research ·Jennifer Selever,Guowei Gu,Michael T. Lewis,Amanda Beyer,Matthew H. Herynk,Kyle R. Covington,Anna Tsimelzon,Gabriela Dontu,Patrick Provost,Attilio Di Pietro,Ahcène Boumendjel,Kathy S. Albain,Lucio Miele,Heidi L. Weiss,Ines Barone,Sebastiano Andò,Suzanne A.W. Fuqua	45
9	Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles 2011 ·Leukemia ·Michael Loudin,Jia‐Bin Wang,(unknown),S. Gurusiddappa,Julia Meyer,(unknown),D. Morrison,Anna Tsimelzon,Meenakshi Devidas,Nyla A. Heerema,Andrew J. Carroll,Sharon E. Plon,Stephen P. Hunger,Giuseppe Basso,Andrea Pession,Deepa Bhojwani,William L. Carroll,Karen R. Rabin	30
10	Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth 2011 ·Breast Cancer Research and Treatment ·Angelo Casà,(unknown),Simeen Malik,ZaWaunyka Lazard,Isere Kuiatse,Hee-Tae Kim,Anna Tsimelzon,Chad J. Creighton,Susan G. Hilsenbeck,(unknown),Steffi Oesterreich,Adrian V. Lee	37
11	High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy 2010 ·Clinical Cancer Research ·Beate C. Litzenburger,Chad J. Creighton,Anna Tsimelzon,(unknown),Susan G. Hilsenbeck,Tao Wang,Joan M. Carboni,Marco M. Gottardis,Fei Huang,Jenny C. Chang,Michael T. Lewis,Mothaffar F. Rimawi,Adrian V. Lee	109
12	Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer 2009 ·Clinical Cancer Research ·Corey Speers,Anna Tsimelzon,K. Sexton,(unknown),Carolina Gutiérrez,Aedín C. Culhane,John Quackenbush,Susan G. Hilsenbeck,Jenny C. Chang,Powel H. Brown	77
13	Prevention of Trauma/Hemorrhagic Shock‐Induced Lung Apoptosis by IL‐6‐Mediated Activation of Stat3 2009 ·Clinical and Translational Science ·Ana Moran,Anna Tsimelzon,(unknown),Yong Wu,Bi Yu,Susan G. Hilsenbeck,Valeria Poli,David J. Tweardy	18
14	SAFB1 Mediates Repression of Immune Regulators and Apoptotic Genes in Breast Cancer Cells 2009 ·Journal of Biological Chemistry ·(unknown),Benny Abraham Kaipparettu,Anna Tsimelzon,Chad J. Creighton,Shiming Jiang,José M. Polo,Ari Melnick,René Meyer,Steffi Oesterreich	31
15	Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution 2008 ·Clinical Cancer Research ·D. Craig Allred,Yun Wu,Sufeng Mao,Irıs D. Nagtegaal,Sangjun Lee,Charles M. Perou,Syed K. Mohsin,P. O’Connell,Anna Tsimelzon,Dan Medina	207
16	Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer 2008 ·Cancer Research ·Mei Zhang,Fariba Behbod,Rachel L. Atkinson,Melissa D. Landis,Frances Kittrell,David G. Edwards,Daniel Medina,Anna Tsimelzon,Susan G. Hilsenbeck,Jeffrey E. Green,Aleksandra M. Michalowska,Jeffrey M. Rosen	260
17	Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function 2008 ·Cancer Research ·Suleiman Massarweh,C. Kent Osborne,Chad J. Creighton,Lanfang Qin,Anna Tsimelzon,Shixia Huang,Heidi L. Weiss,Mothaffar F. Rimawi,Rachel Schiff	375
18	Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor Xenografts 2008 ·Cancer Research ·Chad J. Creighton,Suleiman Massarweh,Shixia Huang,Anna Tsimelzon,Susan G. Hilsenbeck,C. Kent Osborne,Jiang Shou,Luca Malorni,Rachel Schiff	101
19	Hazard rates of recurrence following diagnosis of primary breast cancer 2005 ·Breast Cancer Research and Treatment ·Ismail Jatoi,Anna Tsimelzon,Heidi L. Weiss,Gary M. Clark,Susan G. Hilsenbeck	65
20	Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancerbreakdown → 2003 ·The Lancet ·Jenny C. Chang,Eric C. Wooten,Anna Tsimelzon,Susan G. Hilsenbeck,Maya Gutierrez,Richard Elledge,Syed K. Mohsin,C. Kent Osborne,Gary C. Chamness,D. Craig Allred,P. O’Connell	668

About Anna Tsimelzon

Anna Tsimelzon is a scholar working on Cancer Research, Oncology and Genetics, having authored 62 papers that have together received 5.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Estrogen and related hormone effects (14 papers) and Cancer Cells and Metastasis (12 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (2.6k citations) and Molecular Biology (2.7k citations). Anna Tsimelzon has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Susan G. Hilsenbeck, Jenny C. Chang, C. Kent Osborne, Powel H. Brown, Suzanne A.W. Fuqua, Gordon B. Mills, Syed K. Mohsin, D. Craig Allred, P. O’Connell and Graham M. Poage. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact